IFN- binds to the IFN-/ receptor on the producing cell itself or on neighboring cells, which causes the amplification of iNOS expression and NO production through the signal transducer and activator of transcription (STAT)-mediated signaling [123] (Figure 9)
Lillys Mounjaro, whose main ingredient is tirzepatide, was approved by the FDA in 2022 to treat diabetes, though it has also been used for weight loss
The same L-type Ca 2+ channels can be directly inhibited by NO via S -nitrosylation
Examples of these drugs include: other diabetes drugs that also work to lower blood sugar, such as insulin angiotensin converting enzyme (ACE) inhibitors, such as lisinopril (Prinivil, Zestril) angiotensin II receptor blockers (ARBs), such as valsartan (Diovan) H2-receptor blockers, such as famotidine (Pepcid) certain antifungal drugs, such as fluconazole (Diflucan) miconazole nonsteroidal anti-inflammatory agents (NSAIDs), such as ibuprofen (Advil, Motrin) salicylates, such as aspirin sulfonamides, such as sulfamethoxazole/trimethoprim (Bactrim) warfarin (Jantoven) certain antibiotics, such as: chloramphenicol quinolones probenecid monoamine oxidase inhibitors (MAOIs), such as linezolid (Zyvox) beta-blockers, such as metoprolol (Lopressor, Toprol XL) Some medications can make the warning signs of hypoglycemia less noticeable if theyre taken with glipizide
